Melanie Braig
Hamburg, HH, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Biological Relevance and Therapeutic Potential of the Hypusine Modification System.
Journal: The Journal of biological chemistry
Published: May 14, 2015
Current aspects in resistance against tyrosine kinase inhibitors in chronic myelogenous leukemia.
Journal: Drug discovery today. Technologies
Published: May 23, 2014
A novel mouse model for inhibition of DOHH-mediated hypusine modification reveals a crucial function in embryonic development, proliferation and oncogenic transformation.
Journal: Disease models & mechanisms
Published: May 17, 2014
Proteome analysis of the effects of all-trans retinoic acid on human germ cell tumor cell lines.
Journal: Journal of proteomics
Published: June 27, 2013
Protein-protein-interaction network organization of the hypusine modification system.
Journal: Molecular & cellular proteomics : MCP
Published: August 14, 2012
Molecular characterization of chromosomal band 5p15.33: a recurrent breakpoint region in mantle cell lymphoma involving the TERT-CLPTM1L locus.
Journal: Leukemia research
Published: August 07, 2012
Combination of a proteomics approach and reengineering of meso scale network models for prediction of mode-of-action for tyrosine kinase inhibitors.
Journal: PloS one
Published: June 25, 2012
The metabolite 3-hydroxiglutaric acid effectively reduces glioblastoma growth in vivo by affecting the structural integrity of tumor vasculature.
Journal: Cancer letters
Published: May 04, 2012
Expression of eukaryotic initiation factor 5A and hypusine forming enzymes in glioblastoma patient samples: implications for new targeted therapies.
Journal: PloS one
Published: March 01, 2012
Last Updated: 09/26/2026